LivaNova (NASDAQ:LIVN) Sets New 1-Year High – What’s Next?

Shares of LivaNova PLC (NASDAQ:LIVN) reached a new 52-week high on Monday . The stock traded as high as $84.30 and last traded at $83.81, with a volume of 24692 shares trading hands. The stock had previously closed at $83.62.

Wall Street Analyst Weigh In

Several research firms have recently commented on LIVN. Freedom Capital raised shares of LivaNova to a “hold” rating in a report on Tuesday, June 30th. KeyCorp upped their target price on shares of LivaNova from $83.00 to $92.00 and gave the stock an “overweight” rating in a research report on Monday, June 22nd. Barclays raised their price target on LivaNova from $73.00 to $76.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Mizuho boosted their target price on LivaNova from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Finally, Robert W. Baird dropped their price target on shares of LivaNova from $78.00 to $76.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $80.75.

LivaNova Trading Down 0.5%

The company has a current ratio of 1.33, a quick ratio of 1.11 and a debt-to-equity ratio of 0.24. The business’s 50-day simple moving average is $74.72 and its 200-day simple moving average is $67.94. The company has a market cap of $4.59 billion, a PE ratio of 42.86 and a beta of 0.86.

LivaNova (NASDAQ:LIVN) last issued its earnings results on Wednesday, May 6th. The company reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.13. The firm had revenue of $362.26 million for the quarter, compared to the consensus estimate of $346.05 million. LivaNova had a return on equity of 16.48% and a net margin of 7.48%.The business’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.88 earnings per share. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. As a group, analysts expect that LivaNova PLC will post 3.73 EPS for the current fiscal year.

Insider Transactions at LivaNova

In other LivaNova news, Director Francesco Bianchi sold 1,800 shares of the stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $75.75, for a total transaction of $136,350.00. Following the transaction, the director directly owned 7,228 shares of the company’s stock, valued at $547,521. This represents a 19.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.35% of the company’s stock.

Institutional Investors Weigh In On LivaNova

A number of large investors have recently added to or reduced their stakes in LIVN. Millennium Management LLC grew its holdings in LivaNova by 17.3% during the fourth quarter. Millennium Management LLC now owns 3,484,082 shares of the company’s stock valued at $214,376,000 after purchasing an additional 514,268 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of LivaNova by 83.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock worth $122,858,000 after buying an additional 1,067,349 shares during the period. Vanguard Group Inc. grew its stake in LivaNova by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 2,332,051 shares of the company’s stock valued at $143,491,000 after buying an additional 34,812 shares during the last quarter. AQR Capital Management LLC grew its stake in LivaNova by 29.9% in the 4th quarter. AQR Capital Management LLC now owns 2,155,142 shares of the company’s stock valued at $132,606,000 after buying an additional 496,165 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in LivaNova by 2.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,826,248 shares of the company’s stock worth $116,067,000 after acquiring an additional 38,320 shares during the period. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.